BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 18825744)

  • 1. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
    Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
    Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine.
    Airas L; Niemelä J; Yegutkin G; Jalkanen S
    Ann N Y Acad Sci; 2007 Sep; 1110():641-8. PubMed ID: 17911479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-beta protects from vascular leakage via up-regulation of CD73.
    Kiss J; Yegutkin GG; Koskinen K; Savunen T; Jalkanen S; Salmi M
    Eur J Immunol; 2007 Dec; 37(12):3334-8. PubMed ID: 18034430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.
    Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP
    J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
    Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
    Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties.
    Christensen LD
    APMIS; 1996 Feb; 104(2):126-34. PubMed ID: 8619914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of interferon-beta treatment on the blood-brain barrier.
    Kraus J; Oschmann P
    Drug Discov Today; 2006 Aug; 11(15-16):755-62. PubMed ID: 16846804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Biernacki K; Antel JP; Blain M; Narayanan S; Arnold DL; Prat A
    Arch Neurol; 2005 Apr; 62(4):563-8. PubMed ID: 15824253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.
    Kraus J; Ling AK; Hamm S; Voigt K; Oschmann P; Engelhardt B
    Ann Neurol; 2004 Aug; 56(2):192-205. PubMed ID: 15293271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.
    Trojano M; Defazio G; Avolio C; Paolicelli D; Giuliani F; Giorelli M; Livrea P
    J Neurovirol; 2000 May; 6 Suppl 2():S47-51. PubMed ID: 10871785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
    Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
    Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells.
    Yegutkin GG; Henttinen T; Samburski SS; Spychala J; Jalkanen S
    Biochem J; 2002 Oct; 367(Pt 1):121-8. PubMed ID: 12099890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
    Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
    Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.
    Niemelä J; Henttinen T; Yegutkin GG; Airas L; Kujari AM; Rajala P; Jalkanen S
    J Immunol; 2004 Feb; 172(3):1646-53. PubMed ID: 14734746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.
    Bellingan G; Maksimow M; Howell DC; Stotz M; Beale R; Beatty M; Walsh T; Binning A; Davidson A; Kuper M; Shah S; Cooper J; Waris M; Yegutkin GG; Jalkanen J; Salmi M; Piippo I; Jalkanen M; Montgomery H; Jalkanen S
    Lancet Respir Med; 2014 Feb; 2(2):98-107. PubMed ID: 24503265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1.
    Prat A; Biernacki K; Antel JP
    J Autoimmun; 2005 Mar; 24(2):119-24. PubMed ID: 15829404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure.
    Fujita M; Asakura M; Sanada S; Funaya H; Tsukamoto O; Komamura K; Asanuma H; Taketani S; Isomura T; Nakamaru K; Furukawa H; Sawa Y; Hori M; Kitakaze M
    J Card Fail; 2008 Jun; 14(5):426-30. PubMed ID: 18514936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion.
    Chadjichristos CE; Scheckenbach KE; van Veen TA; Richani Sarieddine MZ; de Wit C; Yang Z; Roth I; Bacchetta M; Viswambharan H; Foglia B; Dudez T; van Kempen MJ; Coenjaerts FE; Miquerol L; Deutsch U; Jongsma HJ; Chanson M; Kwak BR
    Circulation; 2010 Jan; 121(1):123-31. PubMed ID: 20026782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
    Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH
    J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
    Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.